Table 1.
Baseline characteristics of the cases before S. maltophilia initial infection
| Total (n) | 34 |
|---|---|
| Sex (male/female) | 15/19 |
| CFTR F508 del homozygous, % (n) | 44% (15) |
| FEV1pp, mean (SD) | |
| 2 years before S. maltophilia infection | 81 (19) |
| 1 year before S. maltophilia infection | 74 (22) |
| At S. maltophilia infection | 72 (21) |
| Average decrease/yr | 4.3 (1.4) |
| BMI (Z‐score), mean (SD) | −1.08 (1.43) |
| Annual rates of respiratory exacerbations, mean (SD) | 3.3 (1.7) |
| Annual rates of hospitalizations, mean (SD) | 1.1 (1.2) |
| Number of patients with intravenous antibiotic courses, % (n) | 52% (15) |
| P. aeruginosa colonization, % (n) | 8.8% (3) |
| MRSA colonization, % (n) | 8.8% (3) |
CFTR, cystic fibrosis transmembrane regulator; FEV1pp, forced expiratory volume in one second percent predicted; BMI, body mass index; P. aeruginosa, Pseudomonas aeruginosa; MRSA, methicillin‐resistant Staphyloccocus aureus.
The data are the means (SD) or numbers (%) unless otherwise indicated.